|
|
Volumn 42, Issue 4, 1998, Pages 987-988
|
|
New antimicrobial agents approved by the U.S. Food and Drug Administration in 1997 and new indications for previously approved agents
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ANTIVIRUS AGENT;
AZITHROMYCIN;
BUTENAFINE;
BUTOCONAZOLE;
CEFEPIME;
CEFPODOXIME PROXETIL;
CEFUROXIME AXETIL;
CICLOPIROXOLAMINE;
CIPROFLOXACIN;
CLARITHROMYCIN;
DELAVIRDINE;
DIRITHROMYCIN;
FAMCICLOVIR;
FEMSTAT ONE;
GREPAFLOXACIN;
ITRACONAZOLE;
KETOCONAZOLE;
METRONIDAZOLE;
NELFINAVIR;
OXICONAZOLE;
PSEUDOMONIC ACID;
SULTAMICILLIN;
TERBINAFINE;
TIMENTIN;
TIOCONAZOLE;
TOBRAMYCIN SULFATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VAGISTAT 1;
VALACICLOVIR;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
CHRONIC BRONCHITIS;
DRUG APPROVAL;
DRUG INDICATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVAGINAL DRUG ADMINISTRATION;
MYCOSIS;
NOTE;
ORAL DRUG ADMINISTRATION;
OTITIS MEDIA;
PRIORITY JOURNAL;
SKIN INFECTION;
TOPICAL DRUG ADMINISTRATION;
|
|
EID: 0031968182
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/aac.42.4.987 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|